BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Severi C, Carabotti M, Cicenia A, Pallotta L, Annibale B. Recent advances in understanding and managing diverticulitis. F1000Res 2018;7:F1000 Faculty Rev-971. [PMID: 30026920 DOI: 10.12688/f1000research.14299.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Pallotta L, Vona R, Maselli MA, Cicenia A, Bella A, Ignazzi A, Carabotti M, Cappelletti M, Gioia A, Tarallo M, Tellan G, Fiori E, Pezzolla F, Matarrese P, Severi C. Oxidative imbalance and muscular alterations in diverticular disease. Digestive and Liver Disease 2022. [DOI: 10.1016/j.dld.2022.02.001] [Reference Citation Analysis]
2 Piccioni A, Franza L, Vaccaro V, Saviano A, Zanza C, Candelli M, Covino M, Franceschi F, Ojetti V. Microbiota and Probiotics: The Role of Limosilactobacillus Reuteri in Diverticulitis. Medicina (Kaunas) 2021;57:802. [PMID: 34441008 DOI: 10.3390/medicina57080802] [Reference Citation Analysis]
3 Carabotti M, Annibale B. Mesalamine (5-ASA) for the prevention of recurrent diverticulitis (Review). Tech Coloproctol 2019;23:597-9. [PMID: 31346815 DOI: 10.1007/s10151-019-02037-3] [Reference Citation Analysis]
4 Piccioni A, Franza L, Brigida M, Zanza C, Torelli E, Petrucci M, Nicolò R, Covino M, Candelli M, Saviano A, Ojetti V, Franceschi F. Gut Microbiota and Acute Diverticulitis: Role of Probiotics in Management of This Delicate Pathophysiological Balance. J Pers Med 2021;11:298. [PMID: 33919818 DOI: 10.3390/jpm11040298] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Bretto E, D'Amico F, Fiore W, Tursi A, Danese S. Lactobacillus paracasei CNCM I 1572: A Promising Candidate for Management of Colonic Diverticular Disease. J Clin Med 2022;11:1916. [PMID: 35407527 DOI: 10.3390/jcm11071916] [Reference Citation Analysis]